Evidence map›Paper›PMID 32884457›Full record

ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2020

May Measurement Month 2018: an analysis of blood pressure screening results from Argentinean cohort.

Walter G Espeche, Cristina Rojas, Diego Stisman, Analia Fuentes, Mariana Fita, Carlos Diego Lacunza, Diego Marquez, Pedro Grosse, Dennis Bueno, Judith Zilberman and 5 more

Abstract read
In one paragraph

Article in European heart journal supplements : journal of the European Society of Cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. May Measurement Month 2021: an analysis of blood pressure screening results from Argentina.European heart journal supplements : journal of the European Society of Cardiology · 2024
    Article
  2. Review
  3. May Measurement Month 2019: an analysis of blood pressure screening results from Argentina.European heart journal supplements : journal of the European Society of Cardiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Walter G EspecheSociedad Argentina de Hipertensión Arterial, Tte. Gral. Juan Domingo Perón 1479, Piso 2 "4", C1037ACA Ciudad Autónoma de Buenos Aires, Argentina.
Cristina RojasSociedad Argentina de Hipertensión Arterial, Tte. Gral. Juan Domingo Perón 1479, Piso 2 "4", C1037ACA Ciudad Autónoma de Buenos Aires, Argentina.
Diego StismanSociedad Argentina de Hipertensión Arterial, Tte. Gral. Juan Domingo Perón 1479, Piso 2 "4", C1037ACA Ciudad Autónoma de Buenos Aires, Argentina.
Analia FuentesSociedad Argentina de Hipertensión Arterial, Tte. Gral. Juan Domingo Perón 1479, Piso 2 "4", C1037ACA Ciudad Autónoma de Buenos Aires, Argentina.
Mariana FitaSociedad Argentina de Hipertensión Arterial, Tte. Gral. Juan Domingo Perón 1479, Piso 2 "4", C1037ACA Ciudad Autónoma de Buenos Aires, Argentina.
Carlos Diego LacunzaSociedad Argentina de Hipertensión Arterial, Tte. Gral. Juan Domingo Perón 1479, Piso 2 "4", C1037ACA Ciudad Autónoma de Buenos Aires, Argentina.
Diego MarquezSociedad Argentina de Hipertensión Arterial, Tte. Gral. Juan Domingo Perón 1479, Piso 2 "4", C1037ACA Ciudad Autónoma de Buenos Aires, Argentina.
Pedro GrosseSociedad Argentina de Hipertensión Arterial, Tte. Gral. Juan Domingo Perón 1479, Piso 2 "4", C1037ACA Ciudad Autónoma de Buenos Aires, Argentina.
Dennis BuenoSociedad Argentina de Hipertensión Arterial, Tte. Gral. Juan Domingo Perón 1479, Piso 2 "4", C1037ACA Ciudad Autónoma de Buenos Aires, Argentina.
Judith ZilbermanSociedad Argentina de Hipertensión Arterial, Tte. Gral. Juan Domingo Perón 1479, Piso 2 "4", C1037ACA Ciudad Autónoma de Buenos Aires, Argentina.
Thomas BeaneyImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Anca Chis SterImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Neil R PoulterImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Marcos MarínSociedad Argentina de Hipertensión Arterial, Tte. Gral. Juan Domingo Perón 1479, Piso 2 "4", C1037ACA Ciudad Autónoma de Buenos Aires, Argentina.
Irene L EnnisSociedad Argentina de Hipertensión Arterial, Tte. Gral. Juan Domingo Perón 1479, Piso 2 "4", C1037ACA Ciudad Autónoma de Buenos Aires, Argentina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension continues to be the leading cause of death and disability in the industrialized world, with a high level of unawareness and unacceptably poor control. Therefore, the Argentinian Society of Hypertension, in agreement with the May Measurement Month (MMM) initiative of the International Society of Hypertension, implemented for the second consecutive year an educational campaign during the month of May 2018. A volunteer cross-sectional survey was carried out in public spaces and health centres during the month of May 2018 across 33 cities in Argentina. Hypertension was defined as systolic blood pressure (BP) ≥140 mmHg or diastolic BP ≥90 mmHg based on the mean of the 2nd and 3rd of three consecutive BP measurements, or in those on treatment for high BP. Statistical analysis including multiple imputation followed the MMM protocol. A total of 70 418 individuals were screened during MMM18, after excluding those under 18 years old. Of the total, 43.8% of participants were classified as hypertensive, 77.7% were aware of their diagnosis, 69.1% were on pharmacological treatment, and 38.7% were controlled. Of those on antihypertensive medication, 56.0% were controlled. It is necessary to reinforce strategies not only to increase the awareness and control of hypertension but also to identify the population groups, in which these strategies would have the greatest impact, helping to reduce the enormous health burden attributed to hypertension.

Indexed as

Cardiovascular riskEducation for healthHypertensionPopulation-based campaignScreeningSuccessful treatment

Identifiers

PMID32884457
PMCPMC7455283

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.